About RCT Logic
RCT Logic is a Healthcare company based in Ponte Vedra Beach (United States) founded in 2007, and was acquired by PPD in September 2014. Cinical Trial design. RCT Logic has raised $958.03 thousand across 4 funding rounds from investors including PPD. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is RCT Logic, LLC. Its competitors include Trials.ai, HeartcoR and Strategikon Pharma.
Company details
RCT Logic develops and licenses clinical trial designs for use in trials sponsored by industry, non-profit entities, and governments in the United States. RCT Logics flagship product is the Sequential Parallel Comparison Design (SPCD), a clinical trial design paradigm was acquired by Pharmaceutical Product Development (PPD) which will license SPCD as Trimentum. SPDC is a clinical trial design to reduce the detrimental impact of placebo response and addresses the placebo response problem by utilizing placebo non-responders. It also has SPCD comparative analysis software calculator that allows a sponsor of a trial to calculate the design parameters for an SPCD trial under sponsor-provided specifications, and to analyze and understand the efficiency of SPCD in comparison to a conventional trial. SPDC was Dr. Maurizio Fava and Dr. David Schoenfeld of Massachusetts General Hospital (MGH) in 2003.
- Headquarters Ponte Vedra Beach, United States
- Stage Acquired
- SectorsHealthcare
- Website rctlogic.com
- Acquired by PPD (Sep 2014)
- Legal Name Rct Logic, Llc
Funding Insights of RCT Logic
RCT Logic has successfully raised a total of $958.03K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $127.03 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $958,029
- Total Rounds 4
- Last Round Seed — $127,028
- First Round $150,000
(Apr 2010)
All 4 funding rounds of RCT Logic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2013 | $127,028 | Seed | – | – | – |
| Aug 2012 | $175,001 | Seed | – | – | – |
| Oct 2010 | $506,000 | Seed | – | – | – |
| Apr 2010 | $150,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in RCT Logic
RCT Logic has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PPD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRO providing diversified clinical development services | 1985 | ppd.com | Wilmington, United States |
Investor details for RCT Logic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of RCT Logic
4 dated milestones of RCT Logic across 7 years, from founding to its latest funding, stage changes and deals.
- Founded RCT Logic is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Seed, of $127K.
- Exit Acquired by PPD.
Competitors of RCT Logic
RCT Logic has 3 listed competitors in our database. They include Trials.ai, HeartcoR and Strategikon Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| trials.ai | 2014 | San Diego, United States | Provider of AI based trial management solution. | |||
| heartcorsolutions.com | 2015 | Schaumburg, United States | Provides expert ECG recording and analysis for clinical research safety studies. | |||
| strategikonpharma.com | 2016 | San Rafael, United States | Provides SaaS tools for streamlining clinical trial budgeting and vendor oversight. |
Detailed competitors of RCT Logic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as RCT Logic (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RCT Logic
RCT Logic was founded in 2007 and raised its 1st funding round 3 years after it was founded.
RCT Logic is headquartered in Ponte Vedra Beach, United States. It is registered at Ponte Vedra Beach, Florida, United States.
RCT Logic is a funded company, having raised a total of $958.03K across 4 funding rounds to date. The company's 1st funding round was a Seed of $150K, raised on Apr 2010.
RCT Logic develops and licenses clinical trial designs for use in trials sponsored by industry, non-profit entities, and governments in the United States. RCT Logics flagship product is the Sequential Parallel Comparison Design (SPCD), a clinical trial design paradigm was acquired by Pharmaceutical Product Development (PPD) which will license SPCD as Trimentum. SPDC is a clinical trial design to reduce the detrimental impact of placebo response and addresses the placebo response problem by utilizing placebo non-responders. It also has SPCD comparative analysis software calculator that allows a sponsor of a trial to calculate the design parameters for an SPCD trial under sponsor-provided specifications, and to analyze and understand the efficiency of SPCD in comparison to a conventional trial. SPDC was Dr. Maurizio Fava and Dr. David Schoenfeld of Massachusetts General Hospital (MGH) in 2003.
RCT Logic's top competitors include Trials.ai, HeartcoR and Strategikon Pharma.
RCT Logic has 1 investor. Key investors include PPD.
RCT Logic operates through Rct Logic, Llc.
Yes. RCT Logic was acquired by PPD in September 2014.